Skip to main content

  • Cilostazol Works in DAPT for Secondary Stroke Prevention

    • Posted: 02/08/2019
    • Author:

      Nicole Lou, Contributing Writer, MedPage Today

    • 2019News Articles

    Fantastic result' with phosphodiesterase-3 inhibitor

    HONOLULU -- Stroke survivors taking dual antiplatelet therapy (DAPT) with the phosphodiesterase-3 inhibitor cilostazol (Pletaal) plus aspirin or clopidogrel (Plavix) for secondary prevention showed lower risk of recurrent stroke, relative to aspirin/clopidogrel monotherapy, with no trade-off in severe bleeding.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details